The gold-paclitaxel nanoconjugates could overcome MDR through simultaneously preventing the overexpression of Pgp proteins in drug-sensitive cells and evading Pgp-induced drug efflux to achieve potent cancer cell death in drug-resistant cells. The gene discussed is PGP; the disease is cancer.